Advertisement
Research Article| Volume 159, ISSUE 1, P198-203, November 2011

Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1?

  • Peng Xuebing
    Correspondence
    Corresponding author at: Hysterosopic Center, Fuxing Hospital, Capital Medical University, Beijing, 100038, People's Republic of China. Tel.: +86 10 88062277; fax: +86 10 63486922.
    Affiliations
    Hysterosopic Center, Fuxing Hospital, Capital Medical University, Beijing, 100038, People's Republic of China

    Department of Obstetrics and Gynaecology, Jessop Wing, Sheffield Teaching Hospitals and Sheffield Hallam University, Sheffield, S10 2SF, United Kingdom
    Search for articles by this author
  • Li TinChiu
    Affiliations
    Department of Obstetrics and Gynaecology, Jessop Wing, Sheffield Teaching Hospitals and Sheffield Hallam University, Sheffield, S10 2SF, United Kingdom
    Search for articles by this author
  • Xia Enlan
    Affiliations
    Hysterosopic Center, Fuxing Hospital, Capital Medical University, Beijing, 100038, People's Republic of China
    Search for articles by this author
  • Luo Jing
    Affiliations
    Department of Pathology and Histology, Fuxing Hospital, Capital Medical University, Beijing, 100038, People's Republic of China
    Search for articles by this author
  • Huang Xiaowu
    Affiliations
    Hysterosopic Center, Fuxing Hospital, Capital Medical University, Beijing, 100038, People's Republic of China
    Search for articles by this author

      Abstract

      Objective

      Endometrial polyp is a common cause of abnormal uterine bleeding, but the etiology and pathogenesis remain unclear. Vascular endothelial growth factor (VEGF) is angiogenic, related to thick walled vessels and transforming growth factor-beta1 (TGF-β1) is related to fibrotic tissue, which are characteristics of endometrial polyps. The primary objective of this study was to find out if endometrial polyp formation is associated with increased expression of VEGF or TGF-β1, or both. A secondary objective is to determine if the changes are related to steroid receptor expression.

      Study design

      This prospective study compared VEGF and TGF-β1 expression of endometrial polyps and adjacent endometrial tissue in 70 premenopausal women. The comparison of results was separately made for endometrium specimens obtained in the proliferative and secretory phases. The results were correlated with the steroid receptors (estrogen receptor and progesterone receptor) expression.

      Results

      The score of VEGF in glandular cells of endometrial polyps was significantly higher than the score in adjacent endometrium, both in the proliferative phase (P < 0.001) and the secretory phase (P = 0.03); the score of VEGF in stromal cells of endometrial polyps was significantly higher than the score in adjacent endometrium only in proliferative phase (P = 0.006). The score of TGF-β1 in glandular cells of endometrial polyps was significantly higher than the score in adjacent endometrium in proliferative phase (P = 0.02); whereas the score of TGF-β1 in stromal cells of endometrial polyps was significantly higher than the score in adjacent endometrium, both in the proliferative phase (P = 0.006) and the secretory phase (P = 0.008). There was a significant correlation between the expression of steroid receptors and VEGF and TGF-β1 (Spearman's correlation P < 0.001 and P < 0.05, respectively).

      Conclusions

      There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Buckley C.H.
        Normal endometrium and non-proliferative conditions of the endometrium.
        in: Fox H. Wells M. Obstetrical and gynaecological pathology. 5th ed. Elsevier Science Ltd. Press, Oxford2003: 416-417
        • Folkman J.
        What is the evidence that tumors are angiogenesis dependent?.
        J Natl Cancer Inst. 1990; 82: 4-6
        • Carmeliet P.
        • Jain R.K.
        Angiogenesis in cancer and other diseases.
        Nature. 2000; 407: 249-257
        • Wittekindt C.
        • Hess A.
        • Bloch W.
        • Sultanie S.
        • Michel O.
        Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa.
        Eur Arch Otorhinolaryngol. 2002; 259: 294-298
        • Taichman N.S.
        • Young S.
        • Cruchley A.T.
        • Taylor P.
        • Paleolog E.
        Human neutrophils secrete vascular endothelial growth factor.
        J Leukoc Biol. 1997; 62: 397-400
        • Michael D.G.
        • Maria A.O.
        Vascular repair after menstruation involves regulation of vascular endothelial growth factor receptor phosphorylation by FLT-1.
        Am J Pathol. 2001; 158: 1399-1410
        • Albrecht E.D.
        • Babischkin J.S.
        • Lidor Y.
        • et al.
        Effect of estrogen on angiogenesis in co-cultures of human endometrial cells and microvascular endothelial cells.
        Hum Reprod. 2003; 18: 2039-2047
        • Pepper M.S.
        Transforming growth factor-β: vasculogenesis, angiogenesis, and vessel wall integrity.
        Cytokine Growth Factor Rev. 1997; 8: 21-43
        • Border W.A.
        • Noble N.A.
        Transforming growth factor β in tissue fibrosis.
        N Engl J Med. 1994; 331: 1286-1292
        • Peng X.
        • Li T.
        • Xia E.
        • Xia C.
        • Liu Y.
        • Yu D.
        A comparison of oestrogen receptor and progesterone receptor expression in endometrial polyps and endometrium of premenopausal women.
        J Obstet Gynaecol. 2009; 29: 340-346
        • Albrecht E.D.
        • Pepe G.J.
        Steroid hormone regulation of angiogenesis in the primate endometrium.
        Front Biosci. 2003; 8: 416-429
        • Sant’Ana de Almeida E.C.
        • Nogueira A.A.
        • Candido dos Reis F.J.
        • Zambelli Ramalho L.N.
        • Zucoloto S.
        Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women.
        Maturitas. 2004; 49: 229-233
        • Lopes R.G.
        • Baracat E.C.
        • de Albuquerque Neto L.C.
        • et al.
        Analysis of estrogen- and progesterone-receptor expression in endometrial polyps.
        J Minim Invasive Gynecol. 2007; 14: 300-303
        • Mittal K.
        • Schwarz L.
        • Goswami S.
        • Demopoulos R.
        Estrogen and progesterone receptor expression in endometrial polyps.
        Int J Gynecol Pathol. 1996; 15: 345-348
        • Thijs I.
        • Neven P.
        • Van Hooff I.
        • et al.
        Oestrogen and progesterone receptor expression in postmenopausal endometrial polyps and their surrounding endometrium.
        Eur J Cancer. 2000; 36: S93-S118
        • Taylor L.J.
        • Jackson T.L.
        • Reid J.G.
        • Duffy S.G.
        The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps.
        Br J Obstet Gynaecol. 2003; 110: 794-798
        • McGurgan P.
        • Taylor L.J.
        • Duffy S.R.
        • O’Donovan P.J.
        Are endometrial polyps from pre-menopausal women similar to post-menopausal women? An immunohistochemical comparison of endometrial polyps from pre- and post-menopausal women.
        Maturitas. 2006; 54: 277-284
        • Inagaki N.
        • Ung L.
        • Otani T.
        • Wilkinson D.
        • Lopata A.
        Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp.
        Eur J Obstet Gynecol and Reprod Biol. 2003; 111: 197-203
        • Erdemoglu E.
        • Güney M.
        • Karahan N.
        • Mungan T.
        Expression of cyclooxygease-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps.
        Maturitas. 2008; 59: 268-274
        • Torry D.S.
        • Holt V.J.
        • Keenan J.A.
        • et al.
        Vascular endothelial growth factor expression in cycling human endometrium.
        Fertil Steril. 1996; 66: 72-80
        • Shifren J.
        • Tseng J.
        • Zaloudek C.
        • et al.
        Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis.
        J Clin Endocrinol Metab. 1996; 81: 3112-3118
        • Chegini N.
        • Zhao Y.
        • Williams R.S.
        • Flanders K.C.
        Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-β1 (TGF-β1), TGF-β2, TGF-β3, and TGF-β typeII receptor messenger ribonucleic acid and protein and contains [125I] TGF-β1-binding sites.
        Endocrinology. 1994; 135: 439-449
        • Mashburn P.B.
        • Arici A.M.
        • Casey M.L.
        Expression of transforming growth factor-beta1 messenger ribonucleic acid and the modulation of deoxyribonucleic acid synthesis by transforming growth factor-beta 1 in human endometrial cells.
        Am J Obstet Gynecol. 1994; 170: 1152-1158
        • Gold L.I.
        • Saxena B.
        • Mittal K.R.
        • et al.
        Increased expression of transforming growth factor β Isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action.
        Cancer Res. 1994; 54: 2347-2358
        • Girling J.E.
        • Rogers P.A.W.
        Recent advances in endometrial angiogenesis research.
        Angiogenesis. 2005; 8: 89-99
        • Gargett C.E.
        • Rogers P.A.
        Human endometrial angiogenesis.
        Reproduction. 2001; 121: 181-186
        • Ingman W.V.
        • Robertson S.A.
        Defining the actions of transforming growth factor beta in reproduction.
        BioEssays. 2002; 24: 904-914
        • Godkin J.D.
        • Doré J.J.E.
        Transforming growth factor β and the endometrium.
        Rev Reprod. 1998; 3: 1-6
        • Nayak N.R.
        • Brenner R.M.
        Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium.
        J Clin Endocrinol Metab. 2002; 87: 1845-1855
        • Cullinan-Bove K.
        • Koos R.D.
        Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth.
        Endocrinology. 1993; 133: 829-837
        • Ashcroft G.S.
        • Dodsworth J.
        • Van Boxtel E.
        • et al.
        Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta levels.
        Nat Med. 1997; 3: 1195-1196